GlassScriptPhysician profile
Katherine Carruthers
NPI 1558717017
$54,744.18
in general payments reported to CMS, 2019-2025
15 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.65 · 2021: $25K · 2022: $114 · 2023: $1,833 · 2024: $7,111 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $6,574 · Travel and Lodging: $2,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,525.00 |
| Food and Beverage | $6,574.07 |
| Travel and Lodging | $2,442.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $25,529.10 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $25,394.41 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $1,445.59 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Urgo Medical North America, LLC | $791.46 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Coopersurgical, INC. | $306.38 | 2025 | Onetrac Lx, Insorb |
| Kerecis Limited | $295.35 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Innovation Technologies INC | $286.25 | 2023-2024 | Irrisept |
| Acera Surgical, INC. | $177.78 | 2025 | Restrata Wound Matrix |
| Biocircuit Technologies INC | $125.00 | 2025 | Nerve Tape |
| Becton, Dickinson and Company | $121.59 | 2025 | |
| Polarityte, INC. | $88.65 | 2019 | |
| Avita Medical Americas, LLC | $80.01 | 2023 | Recell |
| Abbvie INC. | $48.87 | 2025 | |
| Convatec INC. | $28.46 | 2025 | |
| Smith+Nephew, INC. | $25.28 | 2023 | Oasis, Grafix Pl, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Carruthers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.